Bank of America’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82.1M Buy
653,011
+91,942
+16% +$11.6M 0.01% 1155
2025
Q1
$62.1M Buy
561,069
+77,035
+16% +$8.52M 0.01% 1256
2024
Q4
$66.1M Sell
484,034
-139,554
-22% -$19M 0.01% 1126
2024
Q3
$71.8M Buy
623,588
+4,657
+0.8% +$537K 0.01% 1141
2024
Q2
$85.2M Buy
618,931
+52,218
+9% +$7.19M 0.01% 996
2024
Q1
$78.2M Buy
566,713
+93,734
+20% +$12.9M 0.01% 1058
2023
Q4
$62.3M Sell
472,979
-86,792
-16% -$11.4M 0.01% 1043
2023
Q3
$63M Buy
559,771
+80,033
+17% +$9M 0.01% 1016
2023
Q2
$45.2M Sell
479,738
-69,757
-13% -$6.58M ﹤0.01% 1217
2023
Q1
$55.6M Sell
549,495
-49,851
-8% -$5.05M 0.01% 1148
2022
Q4
$71.6M Sell
599,346
-111,085
-16% -$13.3M 0.01% 955
2022
Q3
$75.5M Buy
710,431
+126,109
+22% +$13.4M 0.01% 888
2022
Q2
$57M Sell
584,322
-11,486
-2% -$1.12M 0.01% 1073
2022
Q1
$55.9M Buy
595,808
+89,721
+18% +$8.41M 0.01% 1164
2021
Q4
$43.1M Sell
506,087
-84,478
-14% -$7.19M ﹤0.01% 1325
2021
Q3
$56.6M Buy
590,565
+10,278
+2% +$986K 0.01% 1146
2021
Q2
$56.5M Sell
580,287
-149,913
-21% -$14.6M 0.01% 1172
2021
Q1
$71M Buy
730,200
+102,071
+16% +$9.93M 0.01% 981
2020
Q4
$60.2M Buy
628,129
+204,046
+48% +$19.6M 0.01% 956
2020
Q3
$40.8M Sell
424,083
-72,654
-15% -$6.99M 0.01% 1088
2020
Q2
$60.6M Buy
496,737
+122,236
+33% +$14.9M 0.01% 867
2020
Q1
$32.4M Sell
374,501
-38,084
-9% -$3.3M 0.01% 1084
2019
Q4
$44.3M Sell
412,585
-8,346
-2% -$897K 0.01% 1107
2019
Q3
$37.9M Sell
420,931
-48,356
-10% -$4.36M 0.01% 1152
2019
Q2
$39.6M Sell
469,287
-46,440
-9% -$3.92M 0.01% 1148
2019
Q1
$45.4M Buy
515,727
+109,807
+27% +$9.67M 0.01% 1045
2018
Q4
$29M Sell
405,920
-200,698
-33% -$14.3M 0.01% 1207
2018
Q3
$74.6M Sell
606,618
-57,176
-9% -$7.03M 0.01% 761
2018
Q2
$65.2M Sell
663,794
-12,353
-2% -$1.21M 0.01% 821
2018
Q1
$56.1M Buy
676,147
+85,272
+14% +$7.07M 0.01% 862
2017
Q4
$45.8M Buy
590,875
+41,664
+8% +$3.23M 0.01% 977
2017
Q3
$33.7M Buy
549,211
+72,341
+15% +$4.43M 0.01% 1262
2017
Q2
$21.9M Buy
476,870
+56,412
+13% +$2.59M ﹤0.01% 1415
2017
Q1
$18.2M Buy
420,458
+178,326
+74% +$7.72M ﹤0.01% 1567
2016
Q4
$9.37M Buy
242,132
+16,035
+7% +$621K ﹤0.01% 2024
2016
Q3
$11.4M Buy
226,097
+120,053
+113% +$6.08M ﹤0.01% 1788
2016
Q2
$4.82M Buy
106,044
+30,046
+40% +$1.37M ﹤0.01% 2370
2016
Q1
$3.01M Sell
75,998
-26,888
-26% -$1.06M ﹤0.01% 2683
2015
Q4
$5.82M Buy
102,886
+14,850
+17% +$840K ﹤0.01% 2267
2015
Q3
$3.5M Buy
88,036
+64,010
+266% +$2.55M ﹤0.01% 2634
2015
Q2
$1.15M Buy
24,026
+18,134
+308% +$866K ﹤0.01% 3185
2015
Q1
$234K Sell
5,892
-2,829
-32% -$112K ﹤0.01% 3932
2014
Q4
$195K Sell
8,721
-1,948
-18% -$43.6K ﹤0.01% 4176
2014
Q3
$167K Sell
10,669
-40,304
-79% -$631K ﹤0.01% 4181
2014
Q2
$757K Buy
50,973
+11,336
+29% +$168K ﹤0.01% 3227
2014
Q1
$638K Buy
39,637
+20,467
+107% +$329K ﹤0.01% 3369
2013
Q4
$179K Buy
19,170
+8,470
+79% +$79.1K ﹤0.01% 4263
2013
Q3
$121K Sell
10,700
-17,186
-62% -$194K ﹤0.01% 4304
2013
Q2
$373K Buy
+27,886
New +$373K ﹤0.01% 3932